Agt (angiotensinogen) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Agt (angiotensinogen) Rattus norvegicus
Analyze
Symbol: Agt
Name: angiotensinogen
RGD ID: 2069
Description: Enables hormone activity. Involved in several processes, including MAPK cascade; positive regulation of amine transport; and regulation of blood pressure. Located in extracellular space. Used to study several diseases, including artery disease (multiple); diabetic retinopathy; gastric ulcer; impotence; and sciatic neuropathy. Biomarker of several diseases, including cerebrovascular disease (multiple); glomerulonephritis (multiple); liver cirrhosis (multiple); lung disease (multiple); and prediabetes syndrome. Human ortholog(s) of this gene implicated in several diseases, including Fabry disease; IgA vasculitis; artery disease (multiple); heart conduction disease (multiple); and hydronephrosis. Orthologous to human AGT (angiotensinogen); PARTICIPATES IN angiotensin (1-7) signaling pathway; angiotensin II signaling pathway via AT2 receptor; angiotensin III signaling pathway via AT1 receptor; INTERACTS WITH (R)-noradrenaline; 1-(5-isoquinolinesulfonyl)-2-methylpiperazine; 11-deoxycorticosterone.
Type: protein-coding
RefSeq Status: PROVISIONAL
Previously known as: Ang; AngII; angiotensin II; angiotensinogen (PAT); angiotensinogen (serpin peptidase inhibitor, clade A, member 8); ANRT; MGC105326; PAT; serpin A8
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Black Rat
Alliance Orthologs
More Info more info ...
Is Marker For: Strains:   SHR.BN-(D19Rat57-D19Mit7)/Ipcv
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81969,426,540 - 69,447,017 (-)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1969,421,638 - 69,446,944 (-)EnsemblGRCr8
mRatBN7.21952,529,139 - 52,549,618 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1952,529,185 - 52,540,977 (-)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1959,313,724 - 59,325,510 (-)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01960,165,792 - 60,177,589 (-)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01962,240,179 - 62,251,965 (-)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01957,321,594 - 57,333,460 (-)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1957,321,640 - 57,333,433 (-)Ensemblrn6Rnor6.0
Rnor_5.01968,026,182 - 68,038,550 (-)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41954,738,556 - 54,750,349 (-)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1951,899,180 - 51,910,819 (-)NCBICelera
RGSC_v3.11954,743,436 - 54,755,230 (-)NCBI
Cytogenetic Map19q12NCBI
JBrowse:




Disease Annotations     Click to see Annotation Detail View
abdominal aortic aneurysm  (ISO)
Albuminuria  (ISO)
alcoholic cardiomyopathy  (ISO)
alcoholic hepatitis  (ISO)
Alkalosis  (ISO)
allergic disease  (ISO)
Alzheimer's disease  (ISO)
Anaphylaxis  (ISO)
anemia  (ISO)
Animal Disease Models  (ISO)
anti-basement membrane glomerulonephritis  (IEP)
anuria  (ISO)
aortic aneurysm  (ISO)
Aortic Calcification  (IDA)
atherosclerosis  (IMP,ISO)
atrial fibrillation  (ISO)
bipolar disorder  (ISO)
Bradycardia  (ISO)
breast cancer  (ISO)
Cardiac Arrhythmias  (ISO)
Cardiomegaly  (IDA,ISO)
cardiomyopathy  (ISO)
Cardiotoxicity  (ISO)
Cardiovascular Abnormalities  (ISO)
cardiovascular system disease  (ISO)
carotid artery disease  (ISO)
Catalepsy  (ISO)
cerebrovascular disease  (ISO)
Chemical and Drug Induced Liver Injury  (ISO)
cholestasis  (ISO)
Chronic Intermittent Hypoxia  (IEP)
chronic myeloid leukemia  (ISO)
cleidocranial dysplasia  (ISO)
coarctation of the aorta  (ISO)
cognitive disorder  (ISO)
congestive heart failure  (IEP,ISO)
corneal neovascularization  (ISO)
coronary artery disease  (ISO)
COVID-19  (ISO)
Diabetic Cardiomyopathies  (ISO)
Diabetic Nephropathies  (ISO)
diabetic retinopathy  (IMP,ISO)
Diaphragmatic Hernia  (ISO)
diffuse scleroderma  (ISO)
dilated cardiomyopathy  (IEP,ISO)
Dissecting Aneurysm  (ISO)
Drug Overdose  (ISO)
end stage renal disease  (ISO)
endomyocardial fibrosis  (ISO)
essential hypertension  (ISO)
Experimental Diabetes Mellitus  (ISO)
Experimental Liver Cirrhosis  (ISO)
Experimental Mammary Neoplasms  (IDA)
Fabry disease  (ISO)
Fetal Growth Retardation  (IEP,ISO)
Fibrosis  (IDA,ISO)
focal segmental glomerulosclerosis  (IEP,ISO)
gastric ulcer  (IDA)
genetic disease  (ISO)
glomerulonephritis  (IEP,ISO)
glucose intolerance  (ISO)
heart disease  (ISO)
Hemorrhage  (ISO)
hydronephrosis  (ISO)
Hyperalgesia  (ISO)
Hyperemia  (ISO)
hyperhomocysteinemia  (ISO)
hyperinsulinism  (ISO)
hypertension  (IDA,IEP,IMP,ISO)
Hypertensive Nephropathy  (IEP)
hypertrophic cardiomyopathy  (ISO)
Hypertrophy  (ISO)
hypokalemia  (ISO)
Hypotension  (ISO)
IgA glomerulonephritis  (ISO)
IgA vasculitis  (ISO)
impotence  (IDA)
Inflammation  (ISO)
inflammatory bowel disease  (ISO)
intermediate coronary syndrome  (ISO)
Intestinal Reperfusion Injury  (IEP)
kidney disease  (ISO)
kidney failure  (ISO)
left ventricular failure  (ISO)
Left Ventricular Hypertrophy  (ISO)
liver cirrhosis  (IEP,ISO)
malignant hypertension  (ISO)
meconium aspiration syndrome  (IEP)
Metabolic Syndrome  (IEP)
microcephaly  (ISO)
middle cerebral artery infarction  (IEP)
mitral valve prolapse  (ISO)
multiple sclerosis  (ISO)
myocardial infarction  (IDA,ISO)
Myocardial Ischemia  (ISO)
Myocardial Reperfusion Injury  (ISO)
Necrosis  (ISO)
Neointima  (ISO)
nephrosis  (ISO)
Neurobehavioral Manifestations  (ISO)
obesity  (ISO)
oligohydramnios  (ISO)
otosclerosis  (ISO)
Peptic Ulcer Hemorrhage  (ISO)
pneumonia  (ISO)
polycystic kidney disease  (IDA)
pre-eclampsia  (ISO)
prediabetes syndrome  (IEP)
Pregnancy-Induced Hypertension  (IEP)
Prenatal Exposure Delayed Effects  (IEP)
primary biliary cholangitis  (IEP)
proteinuria  (ISO)
pulmonary edema  (ISO)
pulmonary fibrosis  (IMP,ISO)
pulmonary hypertension  (IDA)
Puromycin Aminonucleoside Nephrosis  (IEP)
renal hypertension  (ISO)
Renal Tubular Dysgenesis  (ISO)
Reperfusion Injury  (ISO)
retinal vasculitis  (ISO)
retinopathy of prematurity  (ISO)
sciatic neuropathy  (IDA)
sick sinus syndrome  (ISO)
skin melanoma  (ISO)
stroke  (ISO)
Sudden Death  (ISO)
systemic scleroderma  (ISO)
temporal lobe epilepsy  (IEP)
thrombosis  (ISO)
transient cerebral ischemia  (IEP)
type 2 diabetes mellitus  (ISO)
ureteral obstruction  (ISO)
vascular disease  (ISO)
Vascular Malformations  (ISO)
Vascular Remodeling  (ISO)
Ventricular Remodeling  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-catechin  (ISO)
(+)-taxifolin  (ISO)
(1->4)-beta-D-glucan  (ISO)
(R)-lipoic acid  (ISO)
(R)-noradrenaline  (EXP)
(R,R,R)-alpha-tocopherol  (ISO)
(S)-amphetamine  (ISO)
1,2-dichloroethane  (ISO)
1-(5-isoquinolinesulfonyl)-2-methylpiperazine  (EXP)
11-deoxycorticosterone  (EXP)
11-Hydroxyandrostenedione  (ISO)
14,15-EET  (EXP,ISO)
15-deoxy-Delta(12,14)-prostaglandin J2  (EXP)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (EXP)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (ISO)
2,6-di-tert-butyl-4-methylphenol  (ISO)
2,6-dinitrotoluene  (EXP)
2-amino-2-deoxy-D-glucopyranose  (ISO)
3',5'-cyclic GMP  (EXP)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (EXP)
3,3',4,4'-tetrachlorobiphenyl  (ISO)
3,4-methylenedioxymethamphetamine  (ISO)
3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide  (ISO)
3,7-dihydropurine-6-thione  (EXP)
3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea  (ISO)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (EXP,ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-Hydroperoxy-2-nonenal  (ISO)
4-hydroperoxycyclophosphamide  (ISO)
4-hydroxy-TEMPO  (EXP,ISO)
4-hydroxynon-2-enal  (ISO)
4-phenylbutyric acid  (EXP)
5-(2-methylpiperazine-1-sulfonyl)isoquinoline  (EXP)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (EXP)
6-oxoprostaglandin F1alpha  (EXP)
6-propyl-2-thiouracil  (EXP)
7,9-dihydro-1H-purine-2,6,8(3H)-trione  (ISO)
8-Br-cAMP  (ISO)
8-hydroxy-2'-deoxyguanosine  (ISO)
AACOCF3  (EXP)
acadesine  (EXP)
acetamide  (EXP)
acetylcholine  (ISO)
acetylsalicylic acid  (ISO)
actinomycin D  (EXP,ISO)
adefovir  (EXP)
Adenosine, cyclic 3',5'-[hydrogen [p(s)]-phosphorothioate]  (ISO)
aflatoxin B1  (ISO)
aldehydo-D-glucosamine  (ISO)
aldehydo-D-glucose  (EXP,ISO)
aldosterone  (EXP,ISO)
aliskiren  (EXP,ISO)
all-trans-retinoic acid  (EXP,ISO)
allopurinol  (EXP)
alpha-cyano-4-hydroxycinnamic acid  (EXP)
alpha-Zearalanol  (EXP)
amidotrizoic acid  (EXP)
amiloride  (EXP,ISO)
amiodarone  (EXP,ISO)
amitrole  (EXP)
amlodipine  (ISO)
ammonia  (ISO)
ammonium chloride  (EXP)
Ampullosporin  (EXP)
angiotensin II  (ISO)
ANTIMYCIN  (EXP)
apocynin  (EXP,ISO)
arachidonic acid  (ISO)
aristolochic acid A  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (EXP)
aspartame  (ISO)
astressin  (EXP)
atenolol  (ISO)
atorvastatin calcium  (EXP)
Azoxymethane  (ISO)
azoxystrobin  (EXP)
bafilomycin A1  (EXP)
BAPTA  (ISO)
benazepril  (EXP,ISO)
benidipine  (ISO)
benzbromarone  (EXP)
benzo[a]pyrene  (EXP,ISO)
beta-D-glucosamine  (ISO)
beta-endorphin  (EXP)
beta-naphthoflavone  (ISO)
biopterin  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
Bisphenol A diglycidyl ether  (EXP)
bisphenol AF  (ISO)
bisphenol F  (ISO)
boric acid  (ISO)
BQ 123  (EXP,ISO)
brefeldin A  (EXP)
brimonidine tartrate  (EXP)
Brodifacoum  (EXP)
Brusatol  (ISO)
bucladesine  (ISO)
butan-1-ol  (EXP,ISO)
butanal  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (ISO)
caffeine  (EXP)
calciol  (ISO)
calcium atom  (EXP,ISO)
calcium(0)  (EXP,ISO)
Calphostin C  (ISO)
candesartan  (EXP,ISO)
Candesartan cilexetil  (EXP,ISO)
captopril  (EXP,ISO)
carbon monoxide  (ISO)
carbon nanotube  (ISO)
carbonyl cyanide p-trifluoromethoxyphenylhydrazone  (EXP)
carmustine  (ISO)
carvedilol  (EXP,ISO)
CCCP  (EXP)
CGP-42112A  (ISO)
chlorpyrifos  (EXP,ISO)
cholesterol  (EXP,ISO)
chromium atom  (EXP)
chymostatin  (EXP,ISO)
ciglitazone  (EXP)
cisplatin  (ISO)
clofibrate  (EXP,ISO)
clofibric acid  (EXP)
clozapine  (ISO)
cobalt dichloride  (EXP,ISO)
copper atom  (ISO)
copper(0)  (ISO)
copper(II) sulfate  (ISO)
cordycepin  (ISO)
corticosterone  (ISO)
cortisol  (ISO)
crotonaldehyde  (EXP)
Cuprizon  (EXP)
curcumin  (EXP,ISO)
cyclosporin A  (EXP,ISO)
cypermethrin  (EXP)
D-glucose  (EXP,ISO)
DDE  (EXP)
deoxynivalenol  (ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (ISO)
dibenziodolium  (EXP,ISO)
diethyl malate  (ISO)
diminazene diaceturate  (ISO)
dioxygen  (EXP,ISO)
diquat  (ISO)
disodium cromoglycate  (EXP)
diuron  (EXP)
dopamine  (ISO)
dorsomorphin  (EXP,ISO)
doxorubicin  (EXP,ISO)
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor  (EXP,ISO)
efonidipine hydrochloride  (ISO)
elcometrine  (ISO)
ellagic acid  (EXP)
emodin  (EXP)
enalapril  (EXP,ISO)
enalaprilat dihydrate  (EXP,ISO)
endosulfan  (EXP)
eplerenone  (ISO)
ergosta-4,6,8(14),22-tetraen-3-one  (ISO)
ethanol  (EXP,ISO)
ethylene glycol bis(2-aminoethyl)tetraacetic acid  (EXP)
famotidine  (EXP)
fenofibrate  (ISO)
flavonoids  (ISO)
flutamide  (EXP)
folic acid  (EXP,ISO)
fosinopril  (EXP)
fructose  (EXP,ISO)
fulvestrant  (EXP,ISO)
fumonisin B1  (ISO)
furan  (EXP)
furosemide  (ISO)
genistein  (ISO)
gentamycin  (EXP)
Ginkgoic acid  (ISO)
glucose  (EXP,ISO)
glutathione  (ISO)
glutathione disulfide  (ISO)
glycerol  (EXP)
glycochenodeoxycholic acid  (EXP)
glyphosate  (EXP)
goralatide  (ISO)
Harpagide  (ISO)
Harpagoside  (ISO)
heparin  (EXP)
hexadecanoic acid  (ISO)
hydralazine  (EXP,ISO)
hydrazines  (ISO)
hydrogen peroxide  (EXP,ISO)
hydrogen sulfide  (ISO)
ibuprofen  (EXP)
icatibant  (EXP)
ICI 118551  (ISO)
Ile(5)-angiotensin II  (ISO)
imidacloprid  (EXP)
imidaprilat  (ISO)
imperatorin  (EXP)
indometacin  (EXP,ISO)
iohexol  (EXP)
irbesartan  (EXP,ISO)
irinotecan  (ISO)
isoprenaline  (EXP,ISO)
isorhamnetin  (EXP)
isorhapontigenin  (EXP)
ketamine  (EXP,ISO)
ketoconazole  (EXP)
L-ascorbic acid  (EXP,ISO)
L-erythro-biopterin  (ISO)
L-ethionine  (EXP)
labetalol  (ISO)
lactacystin  (EXP)
lead(0)  (EXP,ISO)
levonorgestrel  (ISO)
linoleic acid hydroperoxide  (ISO)
lipoic acid  (ISO)
lipopolysaccharide  (EXP,ISO)
lipoxin A4  (ISO)
lisinopril dihydrate  (EXP,ISO)
losartan  (EXP,ISO)
LY294002  (EXP)
Magnolol  (EXP)
malonaldehyde  (EXP,ISO)
mangiferin  (EXP)
medroxyprogesterone acetate  (ISO)
melatonin  (EXP,ISO)
mercaptopurine  (EXP)
mercury dichloride  (EXP)
metformin  (ISO)
methamphetamine  (EXP)
methimazole  (EXP)
methotrexate  (EXP,ISO)
methylglyoxal  (EXP)
mevalonic acid  (EXP)
Mibefradil  (ISO)
microcystin RR  (ISO)
midostaurin  (EXP)
miquelianin  (ISO)
mithramycin  (EXP)
MK-2206  (ISO)
mono(2-ethylhexyl) phthalate  (ISO)
monocrotaline  (EXP)
montelukast  (ISO)
mycophenolic acid  (EXP)
N(gamma)-nitro-L-arginine methyl ester  (ISO)
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine  (EXP)
N-acetyl-L-cysteine  (EXP,ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (EXP)
N-desethylamiodarone  (ISO)
N-methyl-4-phenylpyridinium  (ISO)
N-methyl-N'-nitro-N-nitrosoguanidine  (ISO)
N-methylnicotinate  (EXP,ISO)
N-nitrosodiethylamine  (EXP,ISO)
N-nitrosodimethylamine  (EXP)
NADP zwitterion  (EXP)
NADP(+)  (EXP)
naloxone  (EXP)
naringin  (ISO)
nebivolol  (EXP)
Neferine  (ISO)
neohesperidin  (EXP,ISO)
nerolidol  (EXP)
nickel atom  (ISO)
nicorandil  (ISO)
nicotinic acid  (EXP,ISO)
nimesulide  (ISO)
nitric oxide  (EXP,ISO)
nitrites  (EXP)
nitrofen  (EXP)
nitrofurantoin  (EXP)
nitroprusside  (ISO)
Nivalenol  (ISO)
NS-398  (EXP)
O-methyleugenol  (ISO)
ochratoxin A  (EXP)
okadaic acid  (ISO)
olmesartan  (EXP,ISO)
oltipraz  (EXP,ISO)
omeprazole  (EXP)
ouabain  (EXP)
ozone  (EXP)
Pachymic acid  (ISO)
paclitaxel  (ISO)
paracetamol  (ISO)
paraquat  (ISO)
parathion  (ISO)
PD 168393  (EXP)
PD123319  (EXP,ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (EXP,ISO)
perindopril  (EXP,ISO)
peroxynitrous acid  (ISO)
phenobarbital  (ISO)
phenylarsine oxide  (EXP)
phenylephrine  (EXP,ISO)
phorbol 13-acetate 12-myristate  (ISO)
phosphatidic acid  (EXP)
phosphoramidon  (EXP)
pifithrin-alpha hydrobromide  (EXP)
pindolol  (ISO)
pioglitazone  (EXP)
pirfenidone  (ISO)
pirinixic acid  (EXP,ISO)
potassium atom  (ISO)
potassium dichromate  (ISO)
pravastatin  (EXP,ISO)
pregabalin  (EXP)
probenecid  (EXP)
progesterone  (ISO)
propanal  (ISO)
propranolol  (ISO)
prostaglandin E1  (ISO)
prostaglandin E2  (EXP)
prostaglandin I2  (EXP)
prostaglandins E  (EXP)
purine-6-thiol  (EXP)
purines  (EXP)
pyrrolidine dithiocarbamate  (EXP)
quercetin  (EXP,ISO)
quinacrine  (ISO)
quinapril hydrochloride  (EXP)
raloxifene  (ISO)
reactive oxygen species  (EXP,ISO)
reboxetine  (ISO)
resveratrol  (EXP,ISO)
rotenone  (EXP,ISO)
rottlerin  (EXP)
rutin  (EXP)
salubrinal  (EXP)
saralasin  (EXP)
SB 203580  (EXP,ISO)
scopolamine  (ISO)
sevoflurane  (ISO)
sildenafil citrate  (ISO)
silicon dioxide  (EXP,ISO)
silver atom  (EXP)
silver(0)  (EXP)
simvastatin  (EXP,ISO)
sirolimus  (EXP)
sodium arsenite  (EXP,ISO)
sodium atom  (EXP,ISO)
sodium chloride  (EXP,ISO)
sodium fluoride  (EXP)
Soman  (EXP)
spironolactone  (EXP,ISO)
streptozocin  (EXP,ISO)
succimer  (ISO)
sucrose  (EXP)
sulfadimethoxine  (EXP)
sulforaphane  (ISO)
sunitinib  (ISO)
superoxide  (EXP,ISO)
tamibarotene  (ISO)
tamoxifen  (ISO)
taurine  (EXP)
taurolithocholic acid sulfate  (EXP)
tauroursodeoxycholic acid  (EXP)
telmisartan  (EXP,ISO)
temozolomide  (ISO)
testosterone  (EXP)
Testosterone propionate  (EXP)
tetrachloromethane  (EXP)
tetracycline  (ISO)
Theaflavin 3,3'-digallate  (EXP)
thenoyltrifluoroacetone  (EXP)
thiabendazole  (EXP)
thioacetamide  (EXP)
thiopental  (ISO)
Thiorphan  (ISO)
Tiron  (EXP,ISO)
titanium dioxide  (EXP,ISO)
torasemide  (EXP)
trandolapril  (EXP,ISO)
trans-piceid  (EXP)
tributylstannane  (EXP,ISO)
trichloroethene  (EXP)
triclosan  (ISO)
triticonazole  (EXP)
troglitazone  (ISO)
tyrphostin AG 1478  (EXP)
U-73122  (EXP)
valproic acid  (ISO)
valsartan  (EXP,ISO)
Vinpocetine  (EXP)
vismodegib  (ISO)
wortmannin  (EXP)
xanthone  (EXP)
xestospongin C  (EXP)
zaragozic acid A  (EXP,ISO)
zearalenone  (ISO)
zinc atom  (EXP,ISO)
zinc protoporphyrin  (ISO)
zinc(0)  (EXP,ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
adenylate cyclase-activating G protein-coupled receptor signaling pathway  (ISO)
aldosterone secretion  (ISO)
angiotensin-activated signaling pathway  (IBA,IEA,ISO,ISS)
angiotensin-mediated drinking behavior  (IDA,IMP)
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure  (ISO)
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure  (ISO)
artery smooth muscle contraction  (IDA)
associative learning  (IDA)
astrocyte activation  (ISO)
blood vessel development  (ISO)
blood vessel diameter maintenance  (IEA)
brain renin-angiotensin system  (ISO)
branching involved in ureteric bud morphogenesis  (ISO)
cell growth involved in cardiac muscle cell development  (IDA)
cell surface receptor signaling pathway  (IDA)
cell-matrix adhesion  (ISO)
cellular response to angiotensin  (IEP)
cellular response to mechanical stimulus  (IEP)
cytokine production  (IDA)
drinking behavior  (ISO)
ERK1 and ERK2 cascade  (IDA)
establishment of blood-nerve barrier  (ISO)
extracellular matrix organization  (ISO)
female pregnancy  (IEP)
fibroblast proliferation  (IDA)
G protein-coupled receptor signaling pathway  (IEA,IMP,ISO)
hormone metabolic process  (ISO)
intracellular sodium ion homeostasis  (IMP)
kidney development  (IEA,ISO)
maintenance of blood vessel diameter homeostasis by renin-angiotensin  (IEA,ISO)
negative regulation of angiogenesis  (IDA)
negative regulation of cell growth  (IMP)
negative regulation of cell population proliferation  (ISO)
negative regulation of gene expression  (ISO)
negative regulation of MAP kinase activity  (ISO)
negative regulation of neuron apoptotic process  (ISO)
negative regulation of neurotrophin TRK receptor signaling pathway  (IEA,ISO)
negative regulation of tissue remodeling  (IDA)
operant conditioning  (IDA)
ovarian follicle rupture  (ISO)
peristalsis  (ISO)
positive regulation of blood pressure  (IDA)
positive regulation of branching involved in ureteric bud morphogenesis  (IEA,ISO)
positive regulation of canonical NF-kappaB signal transduction  (ISO)
positive regulation of cardiac muscle cell apoptotic process  (IDA)
positive regulation of cardiac muscle hypertrophy  (IDA)
positive regulation of cell population proliferation  (IDA)
positive regulation of cholesterol metabolic process  (ISO)
positive regulation of cytokine production  (IEA,ISO)
positive regulation of cytosolic calcium ion concentration  (IDA)
positive regulation of DNA-templated transcription  (IEA,ISO,ISS)
positive regulation of endothelial cell migration  (IEA,ISO)
positive regulation of epidermal growth factor receptor signaling pathway  (IEA,ISO)
positive regulation of epithelial to mesenchymal transition  (ISO,ISS)
positive regulation of extracellular matrix assembly  (ISO)
positive regulation of extracellular matrix constituent secretion  (IDA)
positive regulation of extrinsic apoptotic signaling pathway  (IEA,ISO)
positive regulation of fatty acid biosynthetic process  (ISO)
positive regulation of fibroblast proliferation  (IDA)
positive regulation of gap junction assembly  (IEA,ISO)
positive regulation of gene expression  (ISO)
positive regulation of inflammatory response  (IEA,ISO)
positive regulation of insulin receptor signaling pathway  (IDA)
positive regulation of insulin secretion involved in cellular response to glucose stimulus  (ISO)
positive regulation of L-arginine import across plasma membrane  (IDA)
positive regulation of L-lysine import across plasma membrane  (IDA)
positive regulation of macrophage derived foam cell differentiation  (IEA,ISO)
positive regulation of MAPK cascade  (ISO)
positive regulation of membrane hyperpolarization  (ISO)
positive regulation of miRNA transcription  (ISO)
positive regulation of multicellular organism growth  (ISO)
positive regulation of neuron projection development  (IMP)
positive regulation of nitric oxide biosynthetic process  (IDA)
positive regulation of norepinephrine secretion  (IDA)
positive regulation of organ growth  (ISO)
positive regulation of peptidyl-serine phosphorylation  (ISO)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction  (IEA,ISO)
positive regulation of protein kinase C activity  (ISO)
positive regulation of reactive oxygen species metabolic process  (IEA,ISO)
positive regulation of superoxide anion generation  (IDA)
positive regulation of vascular associated smooth muscle cell migration  (IDA)
positive regulation of vascular associated smooth muscle cell proliferation  (IDA)
protein import into nucleus  (IDA)
regulation of apoptotic process  (IBA,IDA,ISO)
regulation of blood pressure  (IEA,ISO)
regulation of calcium ion transport  (IDA)
regulation of cardiac conduction  (IEA,ISO)
regulation of extracellular matrix assembly  (IEA,ISO)
regulation of gene expression  (ISO)
regulation of heart rate  (IDA)
regulation of inflammatory response  (ISO)
regulation of long-term neuronal synaptic plasticity  (IMP)
regulation of renal output by angiotensin  (ISO)
regulation of systemic arterial blood pressure by circulatory renin-angiotensin  (ISO)
regulation of systemic arterial blood pressure by renin-angiotensin  (IEA)
regulation of transmission of nerve impulse  (IDA)
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure  (ISO)
renal system process  (IEA,ISO)
renin-angiotensin regulation of aldosterone production  (IDA,ISO)
response to angiotensin  (ISO)
response to cold  (ISO)
response to estradiol  (IEP)
response to mechanical stimulus  (IEP)
response to muscle activity involved in regulation of muscle adaptation  (IMP)
response to salt stress  (ISO)
smooth muscle cell differentiation  (ISO)
smooth muscle cell proliferation  (IDA,ISO)
stress-activated MAPK cascade  (IDA)
uterine smooth muscle contraction  (IDA)
vasoconstriction  (IDA,IEA)
vasodilation  (IDA)
vasopressin secretion  (ISO)

Cellular Component
extracellular region  (IEA,ISO)
extracellular space  (IBA,IDA,IEA,ISO)
mitochondrion  (IDA)

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View
References

References - curated
# Reference Title Reference Citation
1. Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant. Ahmad S, etal., Am J Hypertens. 2009 Dec;22(12):1320-5. doi: 10.1038/ajh.2009.181. Epub 2009 Sep 24.
2. Pregnancy protects against antiangiogenic and fibrogenic effects of angiotensin II in rat hearts. Aljabri MB, etal., Acta Physiol (Oxf). 2011 Apr;201(4):445-456. doi: 10.1111/j.1748-1716.2010.02234.x. Epub 2011 Feb 1.
3. Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk? Alokail MS, etal., BMC Cancer. 2013 Feb 4;13:54. doi: 10.1186/1471-2407-13-54.
4. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Alonso-Galicia M, etal., Am J Physiol Regul Integr Comp Physiol 2002 Jul;283(1):R60-8.
5. Angiotensinogen promoter and angiotensinogen II receptor type 1 gene polymorphisms and incidence of ischemic stroke and neurologic phenotype in Fabry disease. Altarescu G, etal., Biomarkers. 2013 Nov;18(7):595-600. doi: 10.3109/1354750X.2013.836244. Epub 2013 Sep 10.
6. Regulation of L-type inward calcium channel activity by captopril and angiotensin II via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts. Alvin Z, etal., Can J Physiol Pharmacol. 2011 Mar;89(3):206-15.
7. Genetic mapping of a neurological mutation cerebellar calcification in the rat. Ando Y, etal., Mamm Genome 2001 Jan;12(1):80-2.
8. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis. Arumugam S, etal., Toxicology. 2012 Jan 27;291(1-3):139-45. doi: 10.1016/j.tox.2011.11.008. Epub 2011 Nov 23.
9. Distinct mechanisms underlie the regulation of body fluid balance by neurokinin B and angiotensin II in the rat brain. Asami R, etal., Brain Res. 2011 Apr 6;1383:179-86. Epub 2011 Jan 28.
10. No evidence for a local renin-angiotensin system in liver mitochondria. Astin R, etal., Sci Rep. 2013;3:2467. doi: 10.1038/srep02467.
11. Lack of association between angiotensinogen polymorphism (M235T) and cerebrovascular disease and carotid atheroma. Barley J, etal., J Hum Hypertens. 1995 Aug;9(8):681-3.
12. The genetic association database. Becker KG, etal., Nat Genet. 2004 May;36(5):431-2.
13. Rat angiotensinogen and des(angiotensin I)angiotensinogen: purification, characterization, and partial sequencing. Bouhnik J, etal., Biochemistry 1981 Nov 24;20(24):7010-5.
14. Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV. Braszko JJ Peptides. 2004 Jul;25(7):1195-203.
15. Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease. Brito VGB, etal., Front Pharmacol. 2020 Nov 11;11:579926. doi: 10.3389/fphar.2020.579926. eCollection 2020.
16. The renin-angiotensin and the kallikrein-kinin systems. Campbell DJ Int J Biochem Cell Biol. 2003 Jun;35(6):784-91.
17. Genetic predisposition to thrombophilia in inflammatory bowel disease. Cappello M, etal., J Clin Gastroenterol. 2011 Mar;45(3):e25-9. doi: 10.1097/MCG.0b013e3181eb6132.
18. Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system. Chakrabarty A, etal., Endocrinology. 2008 Jul;149(7):3452-60. doi: 10.1210/en.2008-0061. Epub 2008 Apr 3.
19. Promoter polymorphism G-6A, which modulates angiotensinogen gene expression, is associated with non-familial sick sinus syndrome. Chen JY, etal., PLoS One. 2012;7(1):e29951. doi: 10.1371/journal.pone.0029951. Epub 2012 Jan 5.
20. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats. Chen L, etal., Eur Rev Med Pharmacol Sci. 2011 Jan;15(1):1-7.
21. Effects of cyclic stretch on the molecular regulation of myocardin in rat aortic vascular smooth muscle cells. Chiu CZ, etal., J Biomed Sci. 2013 Jul 15;20(1):50. doi: 10.1186/1423-0127-20-50.
22. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Colmenero J, etal., Gastroenterology. 2007 Feb;132(2):687-97. Epub 2006 Dec 20.
23. Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. Cook KL, etal., Cancer Res. 2010 Nov 1;70(21):8319-28. Epub 2010 Sep 13.
24. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. D'Amore A, etal., Hypertension. 2005 Dec;46(6):1347-54. Epub 2005 Nov 14.
25. Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function. da Costa Goncalves AC, etal., Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2588-96. Epub 2007 Jul 6.
26. Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea. da Silva AQ, etal., Brain Res. 2011 Jan 12;1368:231-8. Epub 2010 Oct 30.
27. Involvement of the AT1 receptor in the venoconstriction induced by angiotensin II in both the inferior vena cava and femoral vein. da Silva OG, etal., Peptides. 2011 Jan;32(1):112-7. Epub 2010 Oct 16.
28. Renin-angiotensin system gene polymorphisms in children with Henoch-Schonlein purpura in West China. Desong Liu, etal., J Renin Angiotensin Aldosterone Syst. 2010 Dec;11(4):248-55. doi: 10.1177/1470320310374214. Epub 2010 Aug 11.
29. Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo. Echeverria-Rodriguez O, etal., Peptides. 2014 Jan;51:26-30. doi: 10.1016/j.peptides.2013.10.022. Epub 2013 Oct 31.
30. Casein-derived tripeptide Ile-Pro-Pro improves angiotensin-(1-7)- and bradykinin-induced rat mesenteric artery relaxation. Ehlers PI, etal., Life Sci. 2011 Jan 31;88(5-6):206-11. Epub 2010 Nov 4.
31. Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats. Fan YY, etal., Horm Metab Res. 2013 May;45(5):338-43. doi: 10.1055/s-0032-1331256. Epub 2013 Jan 15.
32. AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients. Fatini C, etal., Int J Cardiol. 2008 Jan 24;123(3):293-7. Epub 2007 Mar 26.
33. Thalidomide-induced angiopoietin 2, Notch1 and Dll4 downregulation under hypoxic condition in tissues with gastrointestinal vascular malformation and human umbilical vein endothelial cells. Feng Q, etal., J Dig Dis. 2014 Feb;15(2):85-95. doi: 10.1111/1751-2980.12114.
34. Genetic polymorphisms of the renin-angiotensin system in breast cancer patients. Fishchuk LE and Gorovenko NG, Exp Oncol. 2013 Jun;35(2):101-4.
35. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Fogarty DG, etal., Diabetes. 1996 Sep;45(9):1204-8.
36. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Fradin S, etal., Diabetes Metab. 2002 Feb;28(1):27-32.
37. Analysis of renin-angiotensin-aldosterone system gene polymorphisms in resistant hypertension. Freitas SR, etal., Braz J Med Biol Res. 2007 Mar;40(3):309-16.
38. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia. Fu H, etal., J Hypertens. 2011 Nov;29(11):2210-9. doi: 10.1097/HJH.0b013e32834bbb30.
39. Assessment of biological activity of novel peptide analogues of angiotensin IV. Gard PR, etal., J Pharm Pharmacol. 2011 Apr;63(4):565-71. doi: 10.1111/j.2042-7158.2010.01247.x. Epub 2011 Mar 1.
40. Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage. Gargano JW, etal., Am J Obstet Gynecol. 2009 Sep;201(3):317.e1-9. doi: 10.1016/j.ajog.2009.05.060.
41. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
42. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
43. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk. Gonzalez-Zuloeta Ladd AM, etal., Breast Cancer Res Treat. 2007 Mar;101(3):299-304. Epub 2006 Jul 6.
44. Association Between the M268T Polymorphism in the Angiotensinogen Gene and Essential Hypertension in a South Indian Population. Gopi Chand M, etal., Biochem Genet. 2011 Feb 11.
45. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Goto M, etal., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.
46. The levels of renin-angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Gouveia TL, etal., Neurochem Int. 2012 Jul;61(1):54-62. doi: 10.1016/j.neuint.2012.04.012. Epub 2012 Apr 20.
47. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity. Greco M, etal., Cancer Lett. 2009 Oct 8;283(2):222-9. doi: 10.1016/j.canlet.2009.04.001. Epub 2009 Apr 25.
48. Effects of daily sodium intake and ANG II on cortical and medullary renal blood flow in conscious rats. Gross V, etal., Am J Physiol 1998 May;274(5 Pt 2):R1317-23.
49. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Gutierrez C, etal., Metabolism. 1997 Aug;46(8):976-80.
50. Exercise capacity after coarctation repair relates to the c.46A > G genomic polymorphism of the ss2-adrenoreceptor and the c.704T > C angiotensinogen polymorphism. Hager A, etal., Eur J Prev Cardiol. 2012 Apr;19(2):199-204. doi: 10.1177/1741826711399991. Epub 2011 Feb 25.
51. A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat. Hamilton TA, etal., Peptides. 2001 Jun;22(6):935-44.
52. Angiotensinogen levels in the brain and cerebrospinal fluid of the genetically hypertensive rat. Healy DP and Printz MP, Hypertension 1985 Sep-Oct;7(5):752-9.
53. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. Herath CB, etal., J Hepatol. 2007 Sep;47(3):387-95. Epub 2007 Apr 2.
54. Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hering L, etal., Hypertension. 2010 Aug;56(2):311-8. doi: 10.1161/HYPERTENSIONAHA.110.150961. Epub 2010 Jun 7.
55. Urinary excretion of angiotensin I, II, arginine vasopressin and oxytocin in patients with anaphylactoid reactions. Hermann K, etal., Clin Exp Allergy. 1992 Sep;22(9):845-53.
56. Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma. Hodroj W, etal., Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):525-31. Epub 2006 Dec 14.
57. Association of 3 gene polymorphisms with atopic diseases. Holla L, etal., J Allergy Clin Immunol. 1999 Apr;103(4):702-8.
58. A vaccine for hypertension based on peptide AngI-R: a pilot study. Hong F, etal., Int J Cardiol. 2011 Apr 1;148(1):76-84. doi: 10.1016/j.ijcard.2009.10.027. Epub 2009 Nov 24.
59. Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes. HONG HJ, etal., Acta Pharmacol Sin. 2010 Dec;31(12):1569-75. Epub 2010 Nov 22.
60. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Hsieh TJ, etal., Endocrinology 2002 Aug;143(8):2975-85.
61. Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor. Hsu CN, etal., Int J Mol Sci. 2020 Jun 26;21(12):4552. doi: 10.3390/ijms21124552.
62. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Hunyady L and Catt KJ, Mol Endocrinol. 2006 May;20(5):953-70. Epub 2005 Sep 1.
63. Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7). Igase M, etal., Ther Adv Cardiovasc Dis. 2011 Dec;5(6):297-304. doi: 10.1177/1753944711429343. Epub 2011 Nov 16.
64. Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Imauchi Y, etal., Otol Neurotol. 2008 Apr;29(3):295-301.
65. Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Ishanov A, etal., Am Heart J. 1997 Feb;133(2):184-9.
66. Molecular basis of human hypertension: role of angiotensinogen. Jeunemaitre X, etal., Cell 1992 Oct 2;71(1):169-80.
67. Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines. Kang YM, etal., Toxicol Appl Pharmacol. 2014 Feb 1;274(3):436-44. doi: 10.1016/j.taap.2013.12.001. Epub 2013 Dec 14.
68. Application of angiotensin II to healthy rat sciatic nerve can produce neuropathy without associated vasculopathy. Kasselman LJ and Rutkove SB, Muscle Nerve. 2010 Dec;42(6):959-65. doi: 10.1002/mus.21767. Epub 2010 Sep 30.
69. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y, etal., Arthritis Rheum. 2004 Jan;50(1):216-26.
70. Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Kemp BA, etal., Hypertension. 2012 Aug;60(2):387-95. doi: 10.1161/HYPERTENSIONAHA.112.191403. Epub 2012 Jun 11.
71. Role of intra-renal angiotensin system activation, oxidative stress, inflammation and impaired Nrf2 activity in the progression of focal glomerulosclerosis. Kim HJ, etal., J Pharmacol Exp Ther. 2011 Feb 25.
72. Mechanism of Ang II involvement in activation of NF-kappaB through phosphorylation of p65 during aging. Kim JM, etal., Age (Dordr). 2011 Feb 12.
73. Angiotensinogen messenger RNA stabilization by angiotensin II. Klett CP, etal., J Hypertens Suppl 1996 Dec;14(5):S25-36.
74. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. Kobori H, etal., J Am Soc Nephrol. 2005 Jul;16(7):2073-80. Epub 2005 May 11.
75. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Kramar EA, etal., Brain Res. 2001 Apr 6;897(1-2):114-21.
76. Upregulation of a local renin-angiotensin system in the rat carotid body during chronic intermittent hypoxia. Lam SY, etal., Exp Physiol. 2014 Jan;99(1):220-31. doi: 10.1113/expphysiol.2013.074591. Epub 2013 Sep 13.
77. Targeting the renin-angiotensin system: what's new? Leckie BJ Curr Med Chem Cardiovasc Hematol Agents. 2005 Jan;3(1):23-32.
78. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-{beta}1 pathways in cardiac fibroblasts. Li L, etal., Cardiovasc Res. 2011 Mar 2.
79. Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Liu L, etal., Am J Physiol Renal Physiol. 2011 Dec;301(6):F1195-201. doi: 10.1152/ajprenal.00339.2011. Epub 2011 Aug 24.
80. Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice. Lochard N, etal., J Biol Chem 2003 Jan 24;278(4):2184-9. Epub 2002 Oct 23.
81. Angiotensin II stimulates system y+ and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells. Low BC and Grigor MR, J Biol Chem. 1995 Nov 17;270(46):27577-83.
82. The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Lu J, etal., Neuropeptides. 2013 Oct;47(5):289-95. doi: 10.1016/j.npep.2013.09.002. Epub 2013 Sep 18.
83. Effect of GPE-AGT nanoparticle shRNA transfection system mediated RNAi on early atherosclerotic lesion. Lu P, etal., Int J Clin Exp Pathol. 2012;5(7):698-706. Epub 2012 Sep 5.
84. Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. Lu P, etal., Med Sci Monit. 2011 Sep;17(9):BR248-56.
85. Angiotensin II receptor blockade inhibits pneumocyte apoptosis in experimental meconium aspiration. Lukkarinen H, etal., Pediatr Res. 2004 Feb;55(2):326-33. Epub 2003 Nov 6.
86. [Renin-angiotensin system in mesenteric adipose tissues in rats with metabolic syndrome] Ma LQ, etal., Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Dec;28(6):770-5.
87. [Angiotensinogen gene T174M polymorphism: opposite relationships with essential hypertension and obesity in a homogeneous population from Majorca (Baleric Islands, Spain)] Marco J, etal., Nefrologia. 2005;25(6):629-36.
88. Upregulation of Brain Renin Angiotensin System by 27-Hydroxycholesterol in Alzheimer's Disease. Mateos L, etal., J Alzheimers Dis. 2011 Feb 4.
89. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-kappaB pathway. Meng Y, etal., Am J Respir Cell Mol Biol. 2014 Apr;50(4):723-36. doi: 10.1165/rcmb.2012-0451OC.
90. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
91. ROCK/NF-¿B axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells. Miyata K, etal., Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F608-18. doi: 10.1152/ajprenal.00464.2013. Epub 2014 Jan 15.
92. Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons. Modgil A, etal., Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1116-22. doi: 10.1152/ajpheart.00832.2011. Epub 2011 Dec 23.
93. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Mori T and Cowley AW Jr, Hypertension 2003 Oct;42(4):588-93. Epub 2003 Sep 15.
94. Methylglyoxal augments angiotensin II-induced contraction in rat isolated carotid artery. Mukohda M, etal., J Pharmacol Sci. 2010;114(4):390-8. Epub 2010 Nov 9.
95. Evaluation of kidney dysfunction and angiotensinogen as an early novel biomarker of intrauterine growth restricted offspring rats. Murano Y, etal., Pediatr Res. 2015 Dec;78(6):678-82. doi: 10.1038/pr.2015.153. Epub 2015 Aug 13.
96. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
97. Activation of cardiac renin-angiotensin system in unstable angina. Neri Serneri GG, etal., J Am Coll Cardiol. 2001 Jul;38(1):49-55.
98. ACE2 and ANG-(1-7) in the rat uterus during early and late gestation. Neves LA, etal., Am J Physiol Regul Integr Comp Physiol. 2008 Jan;294(1):R151-61. Epub 2007 Oct 31.
99. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. Ohkubo H, etal., J Biol Chem 1986 Jan 5;261(1):319-23.
100. Cloning and sequence analysis of cDNA for rat angiotensinogen. Ohkubo H, etal., Proc Natl Acad Sci U S A 1983 Apr;80(8):2196-200.
101. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. Olivieri O, etal., J Hypertens. 2001 May;19(5):879-84.
102. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
103. Renin-angiotensin system gene polymorphisms: association with susceptibility to Henoch-Schonlein purpura and renal involvement. Ozkaya O, etal., Clin Rheumatol. 2006 Nov;25(6):861-5. Epub 2006 Mar 7.
104. AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Padia SH and Carey RM, Pflugers Arch. 2013 Jan;465(1):99-110. doi: 10.1007/s00424-012-1146-3. Epub 2012 Sep 5.
105. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Padia SH, etal., Hypertension. 2006 Mar;47(3):537-44. Epub 2005 Dec 27.
106. Survival in type 2 diabetic patients in dialysis and the number of risk alleles in polymorphisms of the renin-angiotensin system genes. Padro-Miquel A, etal., Clin Biochem. 2009 Jan;42(1-2):5-11. doi: 10.1016/j.clinbiochem.2008.10.011. Epub 2008 Nov 5.
107. The predominant role of brain angiotensinogen and angiotensin in environmentally induced hypertension. Peng J, etal., Regul Pept 2002 Dec 31;110(1):25-32.
108. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood. Peng JF, etal., Hypertension. 1998 Jun;31(6):1317-23.
109. Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control. Pignone A, etal., Ann Rheum Dis. 2007 Oct;66(10):1305-10. Epub 2007 Mar 14.
110. Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure. Pilbrow AP, etal., Hypertension. 2007 Feb;49(2):322-7. Epub 2006 Dec 4.
111. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
112. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
113. Genetic analysis of angiotensinogen gene polymorphisms (M235T and T174M) in Romanian patients with essential arterial hypertension. Procopciuc LM, etal., Rom J Intern Med. 2005;43(1-2):61-71.
114. Angiotensin III: a central regulator of vasopressin release and blood pressure. Reaux A, etal., Trends Endocrinol Metab. 2001 May-Jun;12(4):157-62.
115. Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii. Rettig R, etal., Brain Res 1986 Feb 5;364(2):233-40.
116. Studies of the central cardiovascular and dipsogenic effects of angiotensin II in the rat. Rettig R, etal., Clin Exp Hypertens A 1984;6(10-11):2031-5.
117. The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous. Reudelhuber TL Hypertension. 2005 Dec;46(6):1261-2. Epub 2005 Nov 14.
118. GOA pipeline RGD automated data pipeline
119. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
120. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
121. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. Riaz AA, etal., FASEB J. 2004 May;18(7):881-3. doi: 10.1096/fj.03-0502fje. Epub 2004 Mar 4.
122. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. Rijn MJ, etal., J Neurol Neurosurg Psychiatry. 2007 Jan 12;.
123. AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission. Rodriguez-Campos M, etal., Cell Mol Neurobiol. 2000 Dec;20(6):747-62.
124. Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Rojas M, etal., Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1709-18. doi: 10.1167/iovs.09-3375. Epub 2009 Oct 15.
125. Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Sadoshima J and Izumo S, Circ Res. 1993 Sep;73(3):413-23.
126. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Sadoshima J, etal., Cell. 1993 Dec 3;75(5):977-84.
127. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia. Sayitoglu M, etal., J Int Med Res. 2009 Jul-Aug;37(4):1018-28.
128. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. Schelleman H, etal., Eur J Hum Genet. 2007 Apr;15(4):478-84. Epub 2007 Feb 14.
129. No evidence for association between the renin-angiotensin-aldosterone system and otosclerosis in a large Belgian-Dutch population. Schrauwen I, etal., Otol Neurotol. 2009 Dec;30(8):1079-83. doi: 10.1097/MAO.0b013e3181ab3058.
130. Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. Shanmugam P, etal., J Mol Cell Cardiol. 2011 Mar 2.
131. [Effects of Chinese herbal medicine Xuefu Zhuyu Decoction on angiotensin II-induced proliferation and extracellular matrix synthesis of rat cardiac fibroblasts.] Shen Y, etal., Zhong Xi Yi Jie He Xue Bao. 2011 Mar;9(3):313-319.
132. Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation. Shen YJ, etal., J Nat Med. 2014 Jul;68(3):623-9. doi: 10.1007/s11418-014-0825-0. Epub 2014 Mar 5.
133. Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation. Shi R, etal., Cardiovasc Res. 2011 Mar 2.
134. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts. Souza AP, etal., Clin Sci (Lond). 2013 Nov;125(9):449-59. doi: 10.1042/CS20120519.
135. Polymorphisms of renin-angiotensin system genes as a risk factor for high-altitude pulmonary oedema. Stobdan T, etal., J Renin Angiotensin Aldosterone Syst. 2011 Mar 10.
136. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
137. Angiotensin-(1-7) inhibits vascular calcification in rats. Sui YB, etal., Peptides. 2013 Apr;42:25-34. doi: 10.1016/j.peptides.2012.12.023. Epub 2013 Jan 3.
138. Posttranscriptional Control of BNP Gene Expression in Angiotensin II-Induced Hypertension. Suo M, etal., Hypertension 2002 Mar 1;39(3):803-8.
139. Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. Susic D, etal., J Hypertens. 2011 Apr;29(4):716-23.
140. Local renal medullary L-NAME infusion enhances the effect of long-term angiotensin II treatment. Szentivanyi M Jr, etal., Hypertension 1999 Jan;33(1 Pt 2):440-5.
141. Gene-based anchoring of the rat genetic linkage and cytogenetic maps: new regional localizations, orientation of the linkage groups, and insights into mammalian chromosome evolution. Szpirer C, etal., Mamm Genome 1998 Sep;9(9):721-34
142. Angiotensinogen gene polymorphism (Met235Thr) influences visceral obesity and insulin resistance in obese Japanese women. Takakura Y, etal., Metabolism. 2006 Jun;55(6):819-24.
143. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Tallant EA, etal., Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1560-6. Epub 2005 Jun 10.
144. The role of HIF-1, angiopoietin-2, Dll4 and Notch1 in bleeding gastrointestinal vascular malformations and thalidomide-associated actions: a pilot in vivo study. Tan HH, etal., J Dig Dis. 2011 Oct;12(5):349-56. doi: 10.1111/j.1751-2980.2011.00506.x.
145. Common structural organization of the angiotensinogen and the alpha 1-antitrypsin genes. Tanaka T, etal., J Biol Chem 1984 Jul 10;259(13):8063-5.
146. Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study. Tang DC, etal., Am J Hematol. 2001 Nov;68(3):164-9.
147. Renin-angiotensin system gene polymorphisms and atrial fibrillation: a regression approach for the detection of gene-gene interactions in a large hospitalized population. Tsai CT, etal., Cardiology. 2008;111(1):1-7. doi: 10.1159/000113419. Epub 2008 Feb 1.
148. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. Tsuchida S, etal., J Clin Invest 1998 Feb 15;101(4):755-60.
149. Changes in glomerular hemodynamic response to angiotensin II after subacute renal denervation in rats. Tucker BJ, etal., J Clin Invest 1986 Sep;78(3):680-8.
150. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Urushihara M, etal., Hypertension. 2011 Mar;57(3):586-93. Epub 2011 Jan 31.
151. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor. Usui T, etal., Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4370-6. doi: 10.1167/iovs.07-0964.
152. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. van Ittersum FJ, etal., Nephrol Dial Transplant. 2000 Jul;15(7):1000-7.
153. Angiotensinogen promoter sequence variants in essential hypertension. Velez DR, etal., Am J Hypertens. 2006 Dec;19(12):1278-85.
154. ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy. Verma A, etal., Mol Ther. 2012 Jan;20(1):28-36. doi: 10.1038/mt.2011.155. Epub 2011 Jul 26.
155. Rac1 and RhoA differentially regulate angiotensinogen gene expression in stretched cardiac fibroblasts. Verma SK, etal., Cardiovasc Res. 2011 Apr 1;90(1):88-96. Epub 2010 Dec 3.
156. A molecular variant of angiotensinogen associated with preeclampsia. Ward K, etal., Nat Genet 1993 May;4(1):59-61.
157. Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat. Wilkinson-Berka JL, etal., Mol Cell Endocrinol. 2002 Aug 30;194(1-2):201-9.
158. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. Wosik K, etal., J Neurosci. 2007 Aug 22;27(34):9032-42.
159. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells. Xue H, etal., Regul Pept. 2012 Aug 20;177(1-3):12-20. doi: 10.1016/j.regpep.2012.04.002. Epub 2012 May 1.
160. Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamilial hypertrophic or dilated cardiomyopathy. Yamada Y, etal., Am J Hypertens. 1997 Aug;10(8):921-8.
161. Mechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression. Yang C, etal., PLoS One. 2014 Jan 21;9(1):e85785. doi: 10.1371/journal.pone.0085785. eCollection 2014.
162. Activation of the renin-angiotensin system in anti-glomerular basement membrane antibody-induced glomerulonephritis. Yayama K, etal., Biol Pharm Bull. 1995 Mar;18(3):411-5.
163. Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis. Yayama K, etal., Nephron. 1993;63(1):89-93.
164. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. You J, etal., J Cardiovasc Pharmacol. 2013 Feb;61(2):142-51. doi: 10.1097/FJC.0b013e31827a0278.
165. Impairment of Cardiac Function and Remodeling Induced by Myocardial Infarction in Rats are Attenuated by the Nonpeptide Angiotensin-(1-7) Analog AVE 0991. Zeng WT, etal., Cardiovasc Ther. 2010 Dec 19. doi: 10.1111/j.1755-5922.2010.00255.x.
166. Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. Zhang SL, etal., Endocrinology 2002 Dec;143(12):4627-35.
167. Angiotensin (1-7) protects against stress-induced gastric lesions in rats. Zhu D, etal., Biochem Pharmacol. 2014 Feb 1;87(3):467-76. doi: 10.1016/j.bcp.2013.10.026. Epub 2013 Nov 11.
168. Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure. Zong WN, etal., Acta Pharmacol Sin. 2011 Nov;32(11):1345-50. doi: 10.1038/aps.2011.96. Epub 2011 Oct 3.
Additional References at PubMed
PMID:1378723   PMID:4344907   PMID:7622467   PMID:7989296   PMID:8675666   PMID:9196031   PMID:9310306   PMID:9507198   PMID:9557921   PMID:9734405   PMID:9788961   PMID:9852267  
PMID:9878677   PMID:10076178   PMID:10318840   PMID:10406457   PMID:10425188   PMID:11384650   PMID:11606482   PMID:12072911   PMID:12221292   PMID:12431451   PMID:12512691   PMID:12574102  
PMID:12623964   PMID:12657564   PMID:12660888   PMID:12660889   PMID:12697701   PMID:12730191   PMID:12782411   PMID:12874086   PMID:14517903   PMID:14523024   PMID:14674692   PMID:14697237  
PMID:15001568   PMID:15061159   PMID:15087286   PMID:15100095   PMID:15153556   PMID:15213258   PMID:15238256   PMID:15245869   PMID:15489334   PMID:15499027   PMID:15539634   PMID:15561758  
PMID:15582710   PMID:15642775   PMID:15652490   PMID:15659559   PMID:15692220   PMID:15710779   PMID:15803439   PMID:15826947   PMID:15869764   PMID:15922295   PMID:15942049   PMID:15944340  
PMID:16020656   PMID:16051229   PMID:16106038   PMID:16115032   PMID:16115033   PMID:16115039   PMID:16116425   PMID:16146787   PMID:16158334   PMID:16176966   PMID:16322063   PMID:16374517  
PMID:16478781   PMID:16502470   PMID:16522658   PMID:16569213   PMID:16574788   PMID:16585392   PMID:16650497   PMID:16728497   PMID:16780972   PMID:16807546   PMID:16837467   PMID:16864744  
PMID:16933034   PMID:16989733   PMID:17029249   PMID:17060503   PMID:17082724   PMID:17259738   PMID:17327451   PMID:17357790   PMID:17360810   PMID:17404180   PMID:17416596   PMID:17466950  
PMID:17483239   PMID:17491111   PMID:17496209   PMID:17507603   PMID:17513012   PMID:17526654   PMID:17553505   PMID:17616751   PMID:17626897   PMID:17646572   PMID:17664391   PMID:17693541  
PMID:17702818   PMID:17703433   PMID:17706954   PMID:17710629   PMID:17785632   PMID:17878754   PMID:17891894   PMID:17903697   PMID:17914985   PMID:17932313   PMID:17942570   PMID:17962624  
PMID:17980907   PMID:17989112   PMID:18047554   PMID:18077603   PMID:18158338   PMID:18172037   PMID:18192841   PMID:18195168   PMID:18205093   PMID:18216141   PMID:18242696   PMID:18250367  
PMID:18256139   PMID:18256274   PMID:18292392   PMID:18347230   PMID:18359898   PMID:18360053   PMID:18391104   PMID:18391105   PMID:18395010   PMID:18408132   PMID:18420589   PMID:18441197  
PMID:18456730   PMID:18467645   PMID:18559349   PMID:18560380   PMID:18566342   PMID:18607644   PMID:18688015   PMID:18712054   PMID:18760347   PMID:18779436   PMID:18789946   PMID:18790741  
PMID:18806627   PMID:18809792   PMID:18835922   PMID:18838625   PMID:18848828   PMID:18926830   PMID:18945823   PMID:18971210   PMID:18971559   PMID:18986337   PMID:19023134   PMID:19029977  
PMID:19075094   PMID:19118600   PMID:19129738   PMID:19131364   PMID:19147651   PMID:19151253   PMID:19171793   PMID:19211690   PMID:19224536   PMID:19247578   PMID:19258668   PMID:19289825  
PMID:19322025   PMID:19323983   PMID:19326569   PMID:19389807   PMID:19396617   PMID:19399400   PMID:19403863   PMID:19404405   PMID:19407469   PMID:19439822   PMID:19457762   PMID:19460779  
PMID:19587111   PMID:19667256   PMID:19703990   PMID:19710393   PMID:19713680   PMID:19716825   PMID:19717492   PMID:19781194   PMID:19808775   PMID:19811355   PMID:19861503   PMID:19864301  
PMID:19879325   PMID:19948989   PMID:20023119   PMID:20052676   PMID:20056918   PMID:20372825   PMID:20393598   PMID:20423855   PMID:20448043   PMID:20462965   PMID:20535114   PMID:20601126  
PMID:20666571   PMID:20686488   PMID:20724906   PMID:20848345   PMID:20850747   PMID:20962118   PMID:21055442   PMID:21056071   PMID:21108934   PMID:21151982   PMID:21183621   PMID:21186269  
PMID:21265100   PMID:21297982   PMID:21398399   PMID:21510818   PMID:21586345   PMID:21606202   PMID:21613610   PMID:21613793   PMID:21685447   PMID:21705470   PMID:21720156   PMID:21813872  
PMID:21831995   PMID:21900450   PMID:21946693   PMID:21952436   PMID:21959517   PMID:22057271   PMID:22100841   PMID:22101031   PMID:22108917   PMID:22125313   PMID:22302831   PMID:22389386  
PMID:22516433   PMID:22579820   PMID:22684035   PMID:22787147   PMID:22795463   PMID:22811473   PMID:22822941   PMID:22846885   PMID:22853187   PMID:22875344   PMID:22875785   PMID:22913624  
PMID:22923503   PMID:22925777   PMID:23058350   PMID:23117547   PMID:23142109   PMID:23174757   PMID:23220478   PMID:23283998   PMID:23326547   PMID:23365412   PMID:23376485   PMID:23412923  
PMID:23441479   PMID:23528515   PMID:23533145   PMID:23541316   PMID:23608099   PMID:23697773   PMID:23707238   PMID:23754618   PMID:23775122   PMID:23816464   PMID:23825067   PMID:23832698  
PMID:23891689   PMID:24145131   PMID:24184051   PMID:24191285   PMID:24204720   PMID:24296617   PMID:24436324   PMID:24481965   PMID:24710077   PMID:24710423   PMID:24731445   PMID:24771417  
PMID:24824997   PMID:24877125   PMID:24910532   PMID:24976155   PMID:25031298   PMID:25079175   PMID:25099270   PMID:25148511   PMID:25223907   PMID:25246357   PMID:25263961   PMID:25451261  
PMID:25529203   PMID:25732086   PMID:25793389   PMID:25923922   PMID:26090382   PMID:26147666   PMID:26156105   PMID:26310573   PMID:26384348   PMID:26431621   PMID:26674152   PMID:26728324  
PMID:26728369   PMID:26775713   PMID:26824355   PMID:26864937   PMID:26881025   PMID:26970306   PMID:27009340   PMID:27012211   PMID:27068509   PMID:27131988   PMID:27163380   PMID:27225249  
PMID:27465904   PMID:27590241   PMID:27660028   PMID:27871858   PMID:27932705   PMID:27960152   PMID:28011270   PMID:28161727   PMID:28189547   PMID:28283184   PMID:28331185   PMID:28582407  
PMID:28656283   PMID:28656296   PMID:28742157   PMID:28744711   PMID:28988741   PMID:29140411   PMID:29179208   PMID:29262413   PMID:29305157   PMID:29452090   PMID:29746862   PMID:29923351  
PMID:30046277   PMID:30315936   PMID:30412649   PMID:30680929   PMID:31030610   PMID:31708099   PMID:31836539   PMID:31994810   PMID:32000560   PMID:32338644   PMID:32851948   PMID:33010296  
PMID:33129833   PMID:33166587   PMID:33530085   PMID:33687310   PMID:33813849   PMID:34685676   PMID:35405300   PMID:36454502   PMID:36834901   PMID:37667574   PMID:38583954   PMID:38781757  
PMID:39199363  


Genomics

Comparative Map Data
Agt
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81969,426,540 - 69,447,017 (-)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1969,421,638 - 69,446,944 (-)EnsemblGRCr8
mRatBN7.21952,529,139 - 52,549,618 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1952,529,185 - 52,540,977 (-)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1959,313,724 - 59,325,510 (-)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01960,165,792 - 60,177,589 (-)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01962,240,179 - 62,251,965 (-)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01957,321,594 - 57,333,460 (-)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1957,321,640 - 57,333,433 (-)Ensemblrn6Rnor6.0
Rnor_5.01968,026,182 - 68,038,550 (-)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41954,738,556 - 54,750,349 (-)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1951,899,180 - 51,910,819 (-)NCBICelera
RGSC_v3.11954,743,436 - 54,755,230 (-)NCBI
Cytogenetic Map19q12NCBI
AGT
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381230,702,523 - 230,745,583 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1230,690,776 - 230,745,576 (-)Ensemblhg38GRCh38
GRCh371230,838,269 - 230,881,329 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361228,904,892 - 228,916,564 (-)NCBIBuild 36Build 36hg18NCBI36
Build 341227,145,019 - 227,156,602NCBI
Celera1204,104,291 - 204,116,358 (-)NCBICelera
Cytogenetic Map1q42.2NCBI
HuRef1201,323,209 - 201,335,277 (-)NCBIHuRef
CHM1_11232,111,282 - 232,123,349 (-)NCBICHM1_1
T2T-CHM13v2.01230,083,077 - 230,126,137 (-)NCBIT2T-CHM13v2.0
Agt
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm398125,283,326 - 125,296,445 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl8125,283,273 - 125,296,445 (-)EnsemblGRCm39 EnsemblGRCm39
GRCm388124,556,587 - 124,569,706 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl8124,556,534 - 124,569,706 (-)Ensemblmm10GRCm38
MGSCv378127,080,487 - 127,093,607 (-)NCBIMGSCv37MGSCv37mm9NCBIm37
MGSCv368127,442,677 - 127,455,773 (-)NCBIMGSCv36mm8
Celera8128,860,995 - 128,873,954 (-)NCBICelera
Cytogenetic Map8E2NCBI
cM Map872.81NCBI
Agt
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554927,866,833 - 7,873,357 (+)Ensembl
ChiLan1.0NW_0049554927,863,662 - 7,874,863 (+)NCBIChiLan1.0ChiLan1.0
AGT
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2118,492,156 - 18,503,638 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1118,684,644 - 18,696,136 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01206,252,141 - 206,263,830 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11211,279,015 - 211,291,044 (-)NCBIPanPan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1211,279,015 - 211,291,044 (-)EnsemblpanPan2panpan1.1
AGT
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.148,681,192 - 8,694,059 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl48,683,798 - 8,693,880 (+)EnsemblcanFam3CanFam3.1
Dog10K_Boxer_Tasha48,672,874 - 8,685,743 (+)NCBIDog10K_Boxer_TashaDog10K_Boxer_Tasha
ROS_Cfam_1.048,705,485 - 8,718,357 (+)NCBIROS_Cfam_1.0ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl48,705,603 - 8,718,382 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.148,709,653 - 8,722,523 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.048,831,567 - 8,844,457 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.049,061,768 - 9,074,658 (+)NCBIUU_Cfam_GSD_1.0UU_Cfam_GSD_1.0
Agt
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440934443,547,972 - 43,555,916 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493648419,716,165 - 19,721,261 (+)EnsemblSpeTri2.0 Ensembl
SpeTri2.0NW_00493648419,713,299 - 19,721,144 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
AGT
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1459,643,292 - 59,656,833 (+)EnsemblsusScr11Sscrofa11.1
Sscrofa11.11459,643,030 - 59,656,835 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21464,380,799 - 64,385,995 (-)NCBISscrofa10.2Sscrofa10.2susScr3
AGT
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12567,964,840 - 67,977,006 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2567,962,401 - 67,973,324 (-)EnsemblChlSab1.1 EnsemblchlSab2Vervet-AGM
Vero_WHO_p1.0NW_02366605569,870,396 - 69,882,850 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Agt
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462477518,849,118 - 18,855,577 (+)EnsemblHetGla_female_1.0 EnsemblhetGla2HetGla_female_1.0 Ensembl
HetGla 1.0NW_00462477518,846,222 - 18,856,093 (+)NCBIHetGla 1.0HetGla 1.0hetGla2
Agt
(Rattus rattus - black rat)
Black Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rrattus_CSIRO_v11744,081,725 - 44,088,224 (-)NCBIRrattus_CSIRO_v1

miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:205
Count of miRNA genes:157
Interacting mature miRNAs:172
Transcripts:ENSRNOT00000024917
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2313395Anxrr26Anxiety related response QTL 26aggression-related behavior trait (VT:0015014)tameness/aggressiveness composite score (CMO:0002136)194438513474246245Rat
1578764Stresp19Stress response QTL 193.60.001blood renin amount (VT:0003349)plasma renin activity level (CMO:0000116)193253961574246245Rat
5135224Leukc1Leukocyte quantity QTL 1eosinophil quantity (VT:0002602)blood eosinophil count (CMO:0000033)196124916174246245Rat
1331788Rf45Renal function QTL 452.818kidney blood vessel physiology trait (VT:0100012)absolute change in renal blood flow rate (CMO:0001168)193177788874246245Rat
631840Niddm38Non-insulin dependent diabetes mellitus QTL 383.86blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)191032907674246245Rat
724546Kidm3Kidney mass QTL 33.1kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)194622677874246245Rat
7247442Uae39Urinary albumin excretion QTL 39urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)19219431774246245Rat
7411549Bw130Body weight QTL 13050.001body mass (VT:0001259)body weight gain (CMO:0000420)193236531174246245Rat
1549835Tcas7Tongue tumor susceptibility QTL 70.001tongue integrity trait (VT:0010553)squamous cell carcinoma of the head and neck tumor number (CMO:0001876)194172254674246245Rat
1331737Uae29Urinary albumin excretion QTL 295.5urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)193628974246245Rat
724566Uae12Urinary albumin excretion QTL 125urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)19219431774246245Rat
61423Cia14Collagen induced arthritis QTL 143joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)191083361874246245Rat


Related Rat Strains
The following Strains have been annotated to Agt
SHR.BN-(D19Rat57-D19Mit7)/Ipcv    


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
visual system
16 12 61 146 91 90 59 66 59 6 320 160 11 124 77 84 31 17 17

Sequence


Ensembl Acc Id: ENSRNOT00000024917   ⟹   ENSRNOP00000024917
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1969,426,585 - 69,446,944 (-)Ensembl
mRatBN7.2 Ensembl1952,529,185 - 52,540,977 (-)Ensembl
Rnor_6.0 Ensembl1957,321,640 - 57,333,433 (-)Ensembl
Ensembl Acc Id: ENSRNOT00000160760   ⟹   ENSRNOP00000101947
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1969,421,638 - 69,438,377 (-)Ensembl
RefSeq Acc Id: NM_134432   ⟹   NP_602308
RefSeq Status: PROVISIONAL
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81969,426,584 - 69,438,377 (-)NCBI
mRatBN7.21952,529,184 - 52,540,977 (-)NCBI
Rnor_6.01957,321,639 - 57,333,433 (-)NCBI
Rnor_5.01968,026,182 - 68,038,550 (-)NCBI
RGSC_v3.41954,738,556 - 54,750,349 (-)RGD
Celera1951,899,180 - 51,910,819 (-)RGD
Sequence:
RefSeq Acc Id: XM_039097466   ⟹   XP_038953394
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81969,426,540 - 69,447,017 (-)NCBI
mRatBN7.21952,529,139 - 52,549,618 (-)NCBI
RefSeq Acc Id: NP_602308   ⟸   NM_134432
- Peptide Label: precursor
- UniProtKB: P01015 (UniProtKB/Swiss-Prot),   A6KJ10 (UniProtKB/TrEMBL),   A0A8L2UK05 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSRNOP00000024917   ⟸   ENSRNOT00000024917
RefSeq Acc Id: XP_038953394   ⟸   XM_039097466
- Peptide Label: isoform X1
- UniProtKB: A0A8L2UK05 (UniProtKB/TrEMBL)
Ensembl Acc Id: ENSRNOP00000101947   ⟸   ENSRNOT00000160760
Protein Domains
SERPIN

Protein Structures
Name Modeler Protein Id AA Range Protein Structure Video
AF-P01015-F1-model_v2 AlphaFold P01015 1-477 view protein structure  
AGT - Oxidized pdb 2x0b P01015 25-477 view protein structure view video
AGT - Reduced pdb 2x0b P01015 25-477 view protein structure view video
AGT - Renin pdb 2x0b P01015 25-477 view protein structure view video

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13701234
Promoter ID:EPDNEW_R11758
Type:multiple initiation site
Name:Agt_1
Description:angiotensinogen
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01957,333,292 - 57,333,352EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2069 AgrOrtholog
BioCyc Gene G2FUF-5244 BioCyc
Ensembl Genes ENSRNOG00000018445 Ensembl, ENTREZGENE
Ensembl Transcript ENSRNOT00000024917 ENTREZGENE
  ENSRNOT00000160760 ENTREZGENE
Gene3D-CATH 2.30.39.10 UniProtKB/Swiss-Prot
  3.30.497.10 UniProtKB/Swiss-Prot
IMAGE_CLONE IMAGE:7128542 IMAGE-MGC_LOAD
  IMAGE:7318795 IMAGE-MGC_LOAD
InterPro Angiotensinogen UniProtKB/Swiss-Prot
  Angiotensinogen_serpin_dom UniProtKB/Swiss-Prot
  Serpin_dom UniProtKB/Swiss-Prot
  Serpin_fam UniProtKB/Swiss-Prot
  Serpin_sf UniProtKB/Swiss-Prot
  Serpin_sf_1 UniProtKB/Swiss-Prot
  Serpin_sf_2 UniProtKB/Swiss-Prot
KEGG Report rno:24179 UniProtKB/Swiss-Prot
MGC_CLONE MGC:105326 IMAGE-MGC_LOAD
  MGC:93198 IMAGE-MGC_LOAD
NCBI Gene 24179 ENTREZGENE
PANTHER PTHR11461 UniProtKB/Swiss-Prot
  PTHR11461:SF13 UniProtKB/Swiss-Prot
Pfam Serpin UniProtKB/Swiss-Prot
PharmGKB AGT RGD
PhenoGen Agt PhenoGen
PRINTS ANGIOTENSNGN UniProtKB/Swiss-Prot
RatGTEx ENSRNOG00000018445 RatGTEx
SMART SERPIN UniProtKB/Swiss-Prot
Superfamily-SCOP SSF56574 UniProtKB/Swiss-Prot
UniProt A0A8L2UK05 ENTREZGENE, UniProtKB/TrEMBL
  A0ABK0L9V9_RAT UniProtKB/TrEMBL
  A6KJ10 ENTREZGENE, UniProtKB/TrEMBL
  A6KJ11_RAT UniProtKB/TrEMBL
  ANGT_RAT UniProtKB/Swiss-Prot, ENTREZGENE


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-01-20 Agt  angiotensinogen  Agt  angiotensinogen (serpin peptidase inhibitor, clade A, member 8)  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2006-03-30 Agt  angiotensinogen (serpin peptidase inhibitor, clade A, member 8)    angiotensinogen  Name updated 1299863 APPROVED
2002-06-10 Agt  angiotensinogen      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_disease associated with the pathogenesis of essential hypertension and preeclampsia 68691
gene_disease associated with the pathogenesis of essential hypertension and preeclampsia 628425
gene_drugs immunoreactive (IR)-ANG secretion is induced by dexamethasone from renal proximal tubular cells (IRPTCs) in a dose-dependent manner 628563
gene_expression levels in brain and cercbrospinal fluid higher at 4 weeks of agen than at either 7 or 16 weeks, whereas levels in plasma are the reverse, lower at 4 weeks of age than at 7 or 16 weeks 1358967
gene_expression prehypertensive SHR rats (4 weeks of age) show higer levels than in control WKY rats in regions adjacent to the rostral third ventricle; in the evolving phase at 7 weeks of age, levels in 9 brain regions, including the nucleus tractus solitarii, are significantly elevated, whereas at 16 weeks (maintenance phase) only 2 regions show significantly elevated levels in SHR rats 1358967
gene_function helps to increase superoxide in medulalry thick ascending limb (mTAL) which scavenges nitric oxide that increases NaCl absorption in mTAL 1357946
gene_mutations_overexpression the La Jolla colony of SHR rats exhibit a G -> C point mutation at position 1684 of the angiotensinogen gene which appears to affect the secondary structure of the mRNA and strengthen its interaction with a 12 kDa mRNA-stabilizing protein in response to stimulation by angioensin II 1358960
gene_mutations_overexpression deletion of a U-rich region at position 1609-1613 in the3' untranslated region essentially abolishes binding between the angiotensinogen mRNA and a 12 kDa mRNA-stabilizing protein 1358960
gene_other the vasoconstrictive effects of angiotensin II on glomerular hemodynamics are increased after unilateral renal denervation, possibly due to an increase in glomerular angiotensin II receptors 1358965
gene_other microinjection of Angoitensin II into the nucleus tractus solitarii of the brain results in a monophasic decrease in blood pressure at lower doses, and a decrease followed by an increase in blood pressure at higher doses; administration of an angiotensin II receptor antagonist elicits a pressor response and tachycardia implying that angiotensin II acts directly through receptors in the NTS to modulate peripheral cardiovascular responses 1358966
gene_other continuous infusion of angiotensin II into the brains of WKY rats for 20 days resulted in increases in blood pressure, drinking behavior and urination for the duration of the test period. This contradicts results from other groups which reported partial or total habituation during prolonged infusion. 1358968
gene_pathway regulation of expression involves the generation of cellular reactive oxygen species (ROS) and activation of the p38 MAPK signal transduction pathway 628563
gene_pathway elevated circulating level of protein will increase the formation of arachidonate 12-lipoxygenase (Alox12, i.e. 20-HETE) in the kidney and peripheral vasculature 628563
gene_process involved in maintaining blood pressure 68691
gene_process involved in maintaining blood pressure 628425
gene_process potent constrictor of isolated-perfused medullary vasa recta vessels 628563
gene_process high level of circulating Ang II causes resetting of the pressure-natriuresis system to elevated levels of arterial blood pressure through the renal retention of sodium and volume expansion 628563
gene_regulation synthesis and secretion are effected by glucocorticoids, estrogens, thyroid hormones, glucagon and insulin, and are negatively regulated by nephrectomy and both acute and chronic inflammatory conditions 1358960
gene_regulation synthesis and secretion stimulated by angiotensin II through a combination of adenylyl cyclase inhibition and angiotensinogen mRNA sabilization by a 12 kDa polysomal protein 1358960
gene_regulation may cause a rise of renal cortical flow due to reduction in plasma because of incremental increase of daily sodium intake 628563
gene_regulation gene expression is additively increased by high glucose and dexamethasone and this increase is inhibited by insulin 628563
gene_regulation renal medullary nitric oxide (NO) serves as a counter regulatory mechanism to buffer the hypertensive effects of high level angiotensin Ang II 628563
gene_regulation high glucose induces gene expression in immortalized renal proximal tubular cells (IRPTCs) 628563